Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason A Efstathiou

Showing results (81-90 of 278) with videos related to

Pageof 28
Sort By:
International Journal of Radiation Oncology, Biology, Physics|February 25, 2016
A Prospective Comparison of the Effects of Interfractional Variations on Proton Therapy and Intensity Modulated Radiation Therapy for Prostate CancerMaryam Moteabbed, Alexei Trofimov, Gregory C Sharp, et al.
International Journal of Radiation Oncology, Biology, Physics|February 12, 2008
Body mass index and prostate-specific antigen failure following brachytherapy for localized prostate cancerJason A Efstathiou, Rafi Y Skowronski, John J Coen, et al.
European Urology Oncology|April 2, 2019
Combining Immunotherapy with Radiotherapy for the Treatment of Genitourinary MalignanciesAbhishek A Solanki, Alberto Bossi, Jason A Efstathiou, et al.
Nature Reviews. Disease Primers|October 26, 2023
Bladder cancerLars Dyrskjøt, Donna E Hansel, Jason A Efstathiou, et al.
Bladder Cancer (Amsterdam, Netherlands)|January 4, 2024
Longitudinal Analysis of Bladder Cancer-Specific Mortality Trends in the United StatesIsabella R Pompa, David Qi, Anushka Ghosh, et al.
Cancers|February 24, 2024
Radiation Therapy for Stage IIA/B Seminoma: Modeling Secondary Cancer Risk for Protons and VMAT versus 3D PhotonsJennifer Pursley, Kyla Remillard, Nicolas Depauw, et al.
The New England Journal of Medicine|May 23, 2014
Case records of the Massachusetts General Hospital. Case 16-2014. A 46-year-old woman in Botswana with postcoital bleedingDoreen Ramogola-Masire, Anthony H Russell, Scott Dryden-Peterson, et al.
American Journal of Nuclear Medicine and Molecular Imaging|November 24, 2025
Molecular tumor volume on PSMA PET/CT is an independent imaging biomarker associated with progression-free survival in patients with oligorecurrent prostate cancerMonica Cheng, Umar Mahmood, Nathaniel D Mercaldo, et al.
Prostate Cancer and Prostatic Diseases|May 20, 2021
<sup>18</sup>F-Fluciclovine PET/CT performance in biochemical recurrence of prostate cancer: a systematic reviewSoroush Rais-Bahrami, Jason A Efstathiou, Catriona M Turnbull, et al.
European Urology|February 5, 2008
Cardiovascular mortality and duration of androgen deprivation for locally advanced prostate cancer: analysis of RTOG 92-02Jason A Efstathiou, Kyounghwa Bae, William U Shipley, et al.
Pageof 28

Showing results (81-90 of 278) with videos related to

Sort By:
Pageof 28
International Journal of Radiation Oncology, Biology, Physics|February 25, 2016
A Prospective Comparison of the Effects of Interfractional Variations on Proton Therapy and Intensity Modulated Radiation Therapy for Prostate CancerMaryam Moteabbed, Alexei Trofimov, Gregory C Sharp, et al.
International Journal of Radiation Oncology, Biology, Physics|February 12, 2008
Body mass index and prostate-specific antigen failure following brachytherapy for localized prostate cancerJason A Efstathiou, Rafi Y Skowronski, John J Coen, et al.
European Urology Oncology|April 2, 2019
Combining Immunotherapy with Radiotherapy for the Treatment of Genitourinary MalignanciesAbhishek A Solanki, Alberto Bossi, Jason A Efstathiou, et al.
Nature Reviews. Disease Primers|October 26, 2023
Bladder cancerLars Dyrskjøt, Donna E Hansel, Jason A Efstathiou, et al.
Bladder Cancer (Amsterdam, Netherlands)|January 4, 2024
Longitudinal Analysis of Bladder Cancer-Specific Mortality Trends in the United StatesIsabella R Pompa, David Qi, Anushka Ghosh, et al.
Cancers|February 24, 2024
Radiation Therapy for Stage IIA/B Seminoma: Modeling Secondary Cancer Risk for Protons and VMAT versus 3D PhotonsJennifer Pursley, Kyla Remillard, Nicolas Depauw, et al.
The New England Journal of Medicine|May 23, 2014
Case records of the Massachusetts General Hospital. Case 16-2014. A 46-year-old woman in Botswana with postcoital bleedingDoreen Ramogola-Masire, Anthony H Russell, Scott Dryden-Peterson, et al.
American Journal of Nuclear Medicine and Molecular Imaging|November 24, 2025
Molecular tumor volume on PSMA PET/CT is an independent imaging biomarker associated with progression-free survival in patients with oligorecurrent prostate cancerMonica Cheng, Umar Mahmood, Nathaniel D Mercaldo, et al.
Prostate Cancer and Prostatic Diseases|May 20, 2021
<sup>18</sup>F-Fluciclovine PET/CT performance in biochemical recurrence of prostate cancer: a systematic reviewSoroush Rais-Bahrami, Jason A Efstathiou, Catriona M Turnbull, et al.
European Urology|February 5, 2008
Cardiovascular mortality and duration of androgen deprivation for locally advanced prostate cancer: analysis of RTOG 92-02Jason A Efstathiou, Kyounghwa Bae, William U Shipley, et al.
Pageof 28